References
- Ilstad S T, Sachs D H. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307: 168
- Thomas J M, Carver F M, Kasten-Jolly J, et al. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism. Transplantation 1994; 57: 101
- Verbanac K M, Carver F M, Haisch C E, Thomas J M. A role for transforming growth factor-beta in the veto mechanism in transplant tolerance. Transplantation 1994; 57: 893
- Hewitt C W, Black K S, Dowdy S F, et al. Composite tissue (limb) allografts in rats, III: development of donor-host lymphoid chimeras in long-term survivors. Transplantation 1986; 41: 39
- Henson L E, Hewitt C W, Black K S. Use of regression analysis and the complement-dependent cytotoxicity typing assay for predicting lymphoid chimerism. J Immunol Methods 1988; 114: 139
- Hewitt C W, Black K S, Henson L E, Achauer B M, Nguyen J HT. Lymphocyte chimerism in a full allogeneic composite tissue (rat-limb) allograft model prolonged with cyclosporine. Transplant Proc. 1988; 20: 272
- Dorsch S, Roser B. Suppressor cells in transplantation tolerance, II: identification and probable mode of action of chimeric suppressor T cells. Transplantation 1982; 33: 525
- Ildstad S T, Bluestone J A, Sachs D H. Alloresistance to engraftment of allogeneic donor bone marrow is mediated by an Lyt-2+ T cell in mixed allogeneic reconstitution. J Exp Med. 1986; 163: 1343
- Petz L, Yam P, Wallace R B, et al. Mixed hemopoietic chimerism following bone marrow transplantation for hematologic malignancies. Blood 1987; 70: 1331
- Pierce G E, Watts L M. The role of donor lymphoid cells in the transfer of allograft tolerance. Transplantation 1985; 40: 702
- Sykes M, Eisenthal A, Sachs D H. Mechanism of protection from graft-versus-host disease in murine mixed allogeneic chimeras, I: development of a null cell population suppressive of cell-mediated lymphocytic responses and derived from the syngeneic bone marrow component. J Irnmunol 1988; 140: 2903
- Hewitt C W, Ramsamooj R, Patel M P, Yazdi B, Achauer B M, Black K S. Development of stable mixed T cell chimerism and transplantation tolerance without immune modulation in recipients of vascularized bone marrow transplantation. Transplantation 1990; 50: 766
- Llull R, Ramsamooj R, Black K S, Hewitt C W. Cellular mechanisms of alloirnmune nonresponsiveness in tolerant mixed lymphocyte chimeras induced by vascularized bone marrow transplants. Transplant Int. 1994; 7: S453
- Hewitt C W, Black K S, Henson L E, Dowdy S F, Philosophe B, Martin D C. Serologic properties of the tripIe antibody-sandwich-agglutination assay (TASLA). J Clin Lab Immunol 1989; 28: 45
- Hewitt C W, Sawyer S, Beck P A, Martin D C. A simple method for the isolation of platelet free lymphocyte suspensions from rat whole blood. J Immunol Methods 1980; 36: 227
- Sokal R R, Rohlf F J. Biometry. W.H. Freeman, San Francisco 1969; 454–477
- Blume K G, Beutler E, Bross K J, Schmidt G M, Sprice W E, Teplitz R L. Genetic markers in human bone marrow transplantation. Am J Hum Genet 1980; 32: 414
- Renherz E L, Geha R, Rappeport J M, et al. Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-missmatched bone marrow for severe combined immunodeficiency. Proc Natl Acad Sci USA 1982; 79: 6047
- Witherspoon R P, Schanfield M S, Storb R, Thomas E D, Giblett E R. Immunoglobulin production of donor origin after bone marrow transplantation for acute leukemia or aplastic anemia. Transplantation 1978; 26: 407
- Ginsburg D, Antin J H, Smith B R, Orkin S H, Rappaport J M. Analysis using DNA sequence polymorphisms. J Clin Invest. 1985; 114: 139
- Minden M D, Messner H A, Belch A. Origin of leukemic relapse after bone marrow transplantation detected by restriction fragment length polymorphism. J Clin Invest. 1985; 75: 91
- Korver K, de Lange G G, van der Bergh R L, et al. Lymphoid chimerism after allogenic bone marrow transplantation: Y-chromatin staining of peripheral T and B lymphocytes and allotyping of serum antiglobulins. Transplantation 1987; 44: 643
- Boyse E A, Carswell E A, Sheid M P, Old L J. Tolerance of Sk-incompatible skin grafts. Nature 1973; 244: 441
- Krown S E, Coico R, Scheid M P, Fernandes G, Good R A. Immune function in fully allogeneic mouse bone marrow chimeras. Clin Immunol Immunopathol 1981; 19: 268
- Norin A J, Emeson E E, Veith F J. Long-term survival of murine allogeneic bone marrow chimeras: effect of antilymphocyte serum and bone marrow dose. J Immunol 1981; 126: 428